Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tu
Sponsored by GOG Foundation, Inc.
Active
$560.9K Funding
4 People
External
Related Topics
ovarian cancer,
combination therapy,
platinum-resistant,
peritoneal cancer,
fallopian-tube cancer
People
Aradhana Kari
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Janiel Cragun
Co-Investigator (COI)
Obstetrics and Gynecology
﹒Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Mitzi Miranda
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor